A type of
immune therapy known as PD - 1 blockade controlled cancer in 77 percent of patients with defects in DNA mismatch repair — the system cells use to spell - check and fix errors in DNA (SN Online: 10/7/15).
Not exact matches
Santa Monica, California - based Kite is developing chimeric antigen receptor T - cell
therapy,
known as a CAR T, which harnesses the body's own
immune cells to recognize and attack malignant cells.
About 3 years ago, when the medications would
no longer keep it under control and he was prescribed a treatment that he deemed unacceptable (
immune - suppressant
therapy), he found the «Specific Carbohydrate Diet».
More precise application of immuno -
therapies and the development of new approaches requires
knowing the detailed
immune landscape of individual patients and tumors.
«If we
know which genes are damaged in a breast cancer patient's
immune system, prevention or even
therapy can be tailored by giving vaccines or perhaps antiviral drugs to reduce the chances of recurrence,» said Friedenson.
Scientists believe that is what happened during a 1999 French gene
therapy trial on a group of 10 young children with X-SCID, an
immune deficiency disorder
known as boy - in - the - bubble syndrome.
With the potential to affect such a diverse array of neurological ailments, many of which have no
known therapy, the hope is that an improved understanding of
immune - CNS interactions will bring to light new paradigms for preventing and treating neurological disease.
Participants also continued to take
immune system — modulating
therapies known to reduce symptoms.
«
Knowing that immune cytokines can change pigment production in melanocytes, while also knowing that chronic inflammation has the potential to increase the number of melanocytes, has clear implications for the design of future therapies to address a set of common skin disorders,» says Dr. Krueger, director of Milstein Research Program and D. Martin Carter Professor in Clinical Investi
Knowing that
immune cytokines can change pigment production in melanocytes, while also
knowing that chronic inflammation has the potential to increase the number of melanocytes, has clear implications for the design of future therapies to address a set of common skin disorders,» says Dr. Krueger, director of Milstein Research Program and D. Martin Carter Professor in Clinical Investi
knowing that chronic inflammation has the potential to increase the number of melanocytes, has clear implications for the design of future
therapies to address a set of common skin disorders,» says Dr. Krueger, director of Milstein Research Program and D. Martin Carter Professor in Clinical Investigation.
Scientists believe that's what happened during a 1999 French gene
therapy trial on a group of 10 infants with X-SCID, an
immune deficiency disorder
known as boy - in - the - bubble syndrome.
Because immunotherapies are becoming increasingly important for cancer
therapy, the investigators examined genes that code for
known immune targets to see if any were amplified, which may predict responsiveness to immunotherapy.
The treatment with the engineered
immune cells, called CAR - T cell
therapy, may work even better if doctors transplant a subset of
immune cells
known as memory T cells, researchers reported February 14...
The LCA2 trials are a rare success for the field of gene
therapy, which has also cured children with the
immune disorder
known as bubble boy disease.
Oncologists have long
known that in rare cases, after patients receive radiation
therapy to shrink a tumor, the
immune system will mount an aggressive response that wipes out not only the tumor, but metastases throughout the body that hadn't been treated with the radiation.
Gene
therapy, which often employs viruses to deliver the good genes to a body's target cells, has been
known to trigger severe
immune responses and was blamed for the death of an 18 - year - old in 1999, who was receiving gene
therapy for a hereditary metabolic disorder.
New research into Amyotrophic Lateral Sclerosis (ALS)-- also
known as motor neuron disease — shows that specific
immune cells may help slow progression of the disease, an important step towards developing new
therapies to treat patients.
ViaCyte's PEC - Encap ™ (also
known as VC - 01) product candidate delivers the same cell
therapy as PEC - Direct but uses a proprietary device called the Encaptra ® Cell Delivery System that is designed to protect the cells from the patient's
immune system.
This is the first dataset, where we tried to capture all
known industry
immune cell
therapy developers.
No matter what you do and how hard you work with people using manual
therapy, exercise, or other modalities — if their nutrition does not match their genetics, doesn't meet their nutritional needs, and doesn't support the health of their digestive,
immune, nervous, and endocrine systems... their recovery may not happen at all.
«Although this form of
therapy is not advised as a substitute for medication or a cure - all, it's been
known to support the
immune system, treating stress factors which may contribute to illness,» says Ryan.
Acupuncture is
known through research in modern times to positively influence
immune system function, gastrointestinal function, and internal organ function and give pain relief (see www.nih.gov website and CAVM
therapies).
Re-directed Autologous T cell
Therapy for drug resistant or refractory CD20 + B cell lymphoma Overview: In this approach,
immune cells (
known as T cells) are taken from the peripheral blood, genetically modified in the laboratory to express a receptor that recognizes B cells, and then expanded to produce large numbers of tumor specific T cells outside -LSB-...]